Biotech Deals Will Bounce Back in 2017 – Bloomberg


Bloomberg

Biotech Deals Will Bounce Back in 2017
Bloomberg
M&A didn’t exactly grind to a halt in 2016; 326 deals worth about $91 billion got done. But that was down from $118 billion in 2015. And those 326 deals marked the lowest number of deals in six years. Shire’s purchase of Baxalta — a resurrection of a

Read More…

Share This: